Intellia Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
50%
€38.49
Target price
31.03.26
€50.00
Performance (%)
-68.33%
End price
14.12.24
€12.19
Summary
This prediction ended on 14.12.24 with a price of €12.19. The BUY prediction by BiotechBee for Intellia Therapeutics Inc performed very badly with a performance of -68.33%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -9.515% | -9.515% | 36.834% |
| iShares Core DAX® | -0.479% | -12.062% | -2.045% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 13.432% |
| iShares Nikkei 225® | -0.143% | -12.633% | 23.574% |
| iShares S&P 500 | -2.266% | -5.049% | 8.654% |
According to BiotechBee what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year